The molecular mechanisms of congenital hypofibrinogenaemia

Cellular and Molecular Life Sciences

Volumn 61, Issue 12, 2004, Pages 1427-1438

  Maghzal, G J ^a   Brennan, S O ^a   Homer, V M ^a   George, P M ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

Afibrinogenaemia; Expression; Fibrinogen; Hypofibrinogenaemia; Mutation; Protein stability; Protein structure

Indexed keywords

FIBRINOGEN; PROTEIN PRECURSOR;

AFIBRINOGENEMIA; ALPHA ANTITRYPSIN DEFICIENCY; ALPHA CHAIN; AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; BETA CHAIN; BIOSYNTHESIS; BLEEDING DISORDER; ENDOPLASMIC RETICULUM; FIBRINOGEN BLOOD LEVEL; FRAMESHIFT MUTATION; HOMOZYGOTE; HUMAN; HYPOFIBRINOGENEMIA; LIVER CELL; LIVER INJURY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ASSEMBLY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

EID: 3042803930     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-3458-8     Document Type: Review

References (76)

1. Blomback B. (1996) Fibrinogen and fibrin - proteins with complex roles in hemostasis and thrombosis. Thromb. Res. 83: 1-75
2. Kant J. A., Fornace A. J., Saxe D., Simon M. I., McBride O. W. and Crabtree G. R. (1985) Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc. Natl. Acad. Sci. USA 82: 2344-2348
3. Yu S., Sher B., Kudryk B. and Redman C. M. (1983) Intracellular assembly of human fibrinogen. J. Biol. Chem. 258: 13407-13410
4. De Marco L., Girolami A., Zimmerman T. S. and Ruggeri Z. M. (1986) von Willebrand factor interaction with the glycoprotein IIb/IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J. Clin. Invest. 77: 1272-1277
5. Lak M., Keihani M., Elahi F., Peyvandi F. and Mannucci P. M. (1999) Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br. J. Haematol. 107: 204-206
6. Antonarakis S. E. (1998) Recommendations for a nomenclature system for human gene mutations. Human mutation 11: 1-3
7. den Dunnen J. T. and Antonarakis S. E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Human mutation 15: 7-12
8. Neerman-Arbez M., de Moerloose P., Bridel C., Honsberger A., Schonborner A., Rossier C. et al. (2000) Mutations in the fibrinogen Aalpha gene account for the majority of cases of congenital afibrinogenemia. Blood 96: 149-152
9. Hall C. E. and Slayter H. S. (1959)The fibrinogen molecule: Its size, shape, and mode of polymerization. J. Biophys. Biochem. Cytol. 5: 11-16
10. Bailey K., Astbury W. T. and Rudall K. M. (1943) Fibrinogen and fibrin as members of the keratin-myosin group. Nature 151: 716
11. Yee V. C., Pratt K. P., Côté H. C. F., Letrong I., Chung D. W., Davie E. W. et al. (1997) Crystal structure of a 30 kDa C-terminal fragment from the γchain of human fibrinogen. Structure 5: 125-138
12. Spraggon G., Everse S. J. and Doolittle R. F. (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389: 455-462
13. Everse S. J., Spraggon G., Veerapandian L., Riley M. and Doolittle R. F. (1998) Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry 37: 8637-8642
14. Watt K. W., Takagi T. and Doolittle R. F. (1978) Amino acid sequence of the beta chain of human fibrinogen: homology with the gamma chain 2. Proc. Natl. Acad. Sci. USA 75: 1731-1735
15. Doolittle R. F., Goldbaum D. M. and Doolittle L. R. (1978) Designation of sequences involved in the 'coiled-coil' interdomainal connections in fibrinogen: constructions of an atomic scale model. J. Mol. Biol. 120: 311-325
16. Doolittle R. F., Cassman K. G., Cottrell B. A. and Friezner S. J. (1977) Amino acid sequence studies on the alpha chain of human fibrinogen. Isolation and characterization of two linked alpha-chained cyanogen bromide fragments from fully cross-linked fibrin. Biochemistry 16: 1715-1719
17. Takagi T. and Doolittle R. F. (1975) Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: aminoterminal sequences of intermediate and terminal fragments. Biochemistry 14: 940-946
18. Mills D. and Karpatkin S. (1970) Heterogeneity of human fibrinogen: possible relation to proteolysis by thrombin and plasmin as studies by SDS-polyacrylamide gel electrophoresis. Biochem. Biophys. Res. Commun. 40: 206-211
19. Veklich Y. I., Gorkun O. V., Medved L. V., Nieuwenhuizen W. and Weisel J. W. (1993) Carboxyl-terminal portions of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated αC fragments on polymerization. J. Biol. Chem. 268: 13577-13585
20. Redman C. M. and Xia H. (2001) Fibrinogen biosynthesis. Assembly, intracellular degradation and association with lipid synthesis and secretion. Ann. N. Y. Acad. Sci. 936: 480-495
21. Huang S., Cao Z., Chung D. W. and Davie E. W. (1996) The role of βγ and αγ complexes in the assembly of human fibrinogen. J. Biol. Chem. 271: 27942-27947
22. Xu W., Chung D. W. and Davie E. W. (1996) The assembly of human fibrinogen. The role of the ammo-terminal and coiled-coil regions of the three chains in the formation of the αγ and βγ heterodimers and αβγ half-molecules. J. Biol. Chem. 271: 27948-27953
23. Zhang J. Z. and Redman C. M. (1994) Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J. Biol. Chem. 269: 652-658
24. Zhang J. Z. and Redman C. (1996) Fibrinogen assembly and secretion. Role of intrachain disulfide loops. J. Biol. Chem. 271: 30083-30088
25. Brennan S. O., Myles T., Peach R. J., Donaldson D. and George P. M. (1990) Albumin Redhill (-1 Arg, 320 Ala → Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc. Natl. Acad. Sci. USA 87: 26-30
26. Brennan S. O. and Nakayama K. (1994) Furin has the proalbumin substrate specificity and serpin inhibitory properties of an in situ hepatic convertase. FEBS Letters 338: 147-151
27. Farrell D. H., Huang S. and Davie E. W. (1993) Processing of the carboxyl 15-amino acid extension in the α-chain of fibrinogen. J. Biol. Chem. 268: 10351-10355
28. Brennan S. O., Peach R. J. and Boswell D. R. (1989) Novel human proalbumin variant with intact dibasic sequence facilitates identification of converting enzyme. Biochim. Biophys. Acta 993: 48-50
29. Brennan S. O., Hammonds B. and George P. M. (1995) Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (Aα20 Val → Asp). J. Clin. Invest. 96: 2854-2858
30. Terasawa F., Okumura N., Kitano K., Hayashida N., Shimosaka M., Okazaki M. et al. (1999) Hypofibrinogenemia associated with a heterozygous missense mutation gamma 153Cys to Arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen. Blood 94: 4122-4131
31. Okumura N., Terasawa F., Tanaka H., Hirota M., Ota H., Kitano K. et al. (2002) Analysis of fibrinogen γ-chain truncations shows the C-terminus, particularly γILe387, is essential for assembly and secretion of this multichain protein. Blood 99: 3654-3660
32. Iida H., Ishii E., Nakahara M., Urata M., Wakiyama M., Kurihara M. et al. (2000) A case of congenital afibrinogenemia: Fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene. Thromb. Haemost. 84: 49-53
33. Brennan S. O., Wyatt J., Medicina D., Callea F. and George P. M. (2000) Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly → Arg mutation. Am. J. Pathol. 157: 189-196
34. Perlmutter D. H. (1998) Alpha-1-antitrypsin deficiency. Seminars in Liver Disease 18: 217-225
35. EC domain from human fibrinogen-420. Proc. Natl. Acad. Sci. USA 95: 9099-9104
36. Carrell R. W. and Stein P. E. (1996) The biostructural pathology of serpins: critical function of sheet opening mechanism. Biol. Chem. Hoppe Seyler 377: 1-17
37. Lomas D. A., Evans D. L., Finch J. T. and Carrell R. W. (1992) The mechanism of Z antitrypsin accumulation in the liver. Nature 357: 605-607
38. Brennan S. O., Maghzal G., Shneider B. L., Gordon R., Magid M. S. and George P. M. (2002) Novel fibrinogen gamma375 Arg → Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 36: 652-658
39. Yakovlev S., Litvinovich S., Loukinov D. and Medved L. (2000) Role of the beta-strand insert in the central domain of the fibrinogen gamma-module. Biochemistry 39: 15721-15729
40. Callea F., Brisigotti M., Fabbretti G., Bonino F. and Desmet V. J. (1992) Hepatic endoplasmic reticulum storage diseases. Liver 12: 357-362
41. Brennan S. O., Wyatt J. M., May S., De Caigney S. and George P. M. (2001) Hypofibrinogenemia due to novel 316 Asp → Tyr substitution in the fibrinogen Bbeta chain. Thromb. Haemost. 85: 450-453
42. Maghzal G. J., Brennan S. O., Fellowes A. P., Spearing R. and George P. M. (2003) Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg → His (Fibrinogen Merivale). Biochim. Biophys. Acta 1645: 146-151
43. Vu D., Bolton-Maggs P. H., Parr J. R., Morris M. A., de Moerloose P. and Neerman-Arbez M. (2003) Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood 102:4413-4415
44. Duga S., Asselta R., Santagostino E., Zeinali S., Simonie T., Malcovati M. et al. (2000) Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 95: 1336-1341
45. Ockelford P. A., Liang A. Y., Wells R. M., Vissers M., Brennan S. O., Williamson D. et al. (1980) Hemoglobin Volga b27 (B9) Ala> Asp: Functional and clinical correlations of an unstable hemoglobin. Hemoglobin 4: 295-306
46. Brennan S. O., Wyatt J. M., Fellowes A. P., Dlott J. S., Triplett D. A. and George P. M. (2001) gamma371 Thr → Ile substitution in the fibrinogen gammaD domain causes hypofibrinogenaemia. Biochim. Biophys. Acta 1550: 183-188
47. Homer V. M., Brennan S. O. and George P. M. (2002) Novel fibrinogen B beta gene mutation causing hypofibrinogenaemia. Thromb. Haemost. 88: 1066-1067
48. Homer V. M., Brennan S. O., Ockelford P. and George P. M. (2002) Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia. Thromb. Haemost. 88: 427-431
49. Neerman-Arbez M., Vu D., Abu-libdeh B., Bouchardy I. and Morris M. A. (2003) Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family. Blood 101: 3492-3494
50. Spena S., Duga S., Asselta R., Malcovati M., Peyvandi F. and Tenchini M. L. (2002) Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bβ-chain gene causing activation of cryptic splice sites. Blood 100: 4478-4484
51. Zhang J. Z. and Redman C. M. (1992) Identification of Bβ chain domains involved in human fibrinogen assembly. J. Biol. Chem. 267: 21727-21732
52. Hanss M. M. L., Ffrench P. O., Mornex J. F., Chabuet M., Biot F., de Mazancourt P. et al. (2003) Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J. Thromb. Haemost. 1: 1251-1257
53. Brennan S. O., Fellowes A. P., Faed J. M. and George P. M. (2000) Hypofibrinogenemia in an individual with 2 coding (gamma82 A → G and Bbeta235 P → L) and 2 noncoding mutations. Blood 95: 1709-1713
54. Wyatt J., Brennan S. O., May S. and George P. M. (2000) Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations-gamma 82 Ala → Gly and an intron two GT → AT splice site mutation. Thromb Haemost 84: 449-452
55. Neerman-Arbez M., de Moerloose P., Honsberger A., Parlier G., Arnuti B., Biron C. et al. (2001) Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum. Genet. 108: 237-240
56. Attanasio C., de Moerloose P., Antonarakis S. E., Morris M. A. and Neerman-Arbez M. (2001) Activation of multiple cryptic donor splice sites by the common afibrinogenemia mutation, FGA IVS+1 G>T. Blood 97: 1879-1881
57. Attanasio C., David A. and Neerman-Arbez M. (2003) Outcome of donor splice site mutaions accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA). Blood 101: 1851-1856
58. Neerman-Arbez M., Honsberger A., Antonarakis S. E. and Morris M. A. (1999) Deletion of the fibrinogen alpha-chain gene (FGA) causes congenital afibrogenemia. J. Clin. Invest. 103: 215-218
59. Stromorken H., Fellowes A. P., George P. M., Brennan S. O. and Brosstad F. (1998) Afibrinogenaemia due to homozygous CGATGA mutation in exon 4 of the fibrinogen Aα gene. Blood. Coag. Fibrinol. 9: 700-701
60. Ridgway H. J., Brennan S. O., Gibbons S. and George P. M. (1996) Fibrinogen Lincoln: a new truncated α chain variant with delayed clotting. Br. J. Haematol. 93: 177-184
61. 461 AAA → Stop TAA). Blood 80: 1972-1979
62. Homer V. M., Mullin J. L., Brennan S. O., Barr A. and George P. M. (2003) Novel A alpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization. J. Thromb. Haemost. 1: 1245-1250
63. Lefebvre P., Velasco P. T., Dear A., Lounes K. C., Lord S. T., Brennan S. O. et al. (2004) Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AIVS4 + 1 G>T mutation and an AGln328 truncation (Fibrinogen Keokuk). Blood 103
64. Ridgway H. J., Brennan S. O., Faed J. M. and George P. M. (1997) Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br. J. Haematol. 98: 632-639
65. Asselta R., Spena S., Duga S., Peyvandi F., Malcovati M. and Tenchini M. L. (2002) Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia. Haematologica 87: 855-859
66. Asselta R., Duga S., Spena S., Santagostino E., Peyvandi F., Piseddu G. et al. (2001) Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen Aalpha-chain gene are not associated with the decay of the mutant mRNAs. Blood 98: 3685-3692
67. Fellowes A. P., Brennan S. O., Holme R., Stormorken H., Brosstad F. R. and George P. M. (2000) Homozygous truncation of the fibrinogen aalpha chain within the coiled coil causes congenital afibrinogenemia. Blood 96: 773-775
68. Roy S. N., Mukhopadhyay G. and Redman C. M. (1990) Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J. Biol. Chem. 265: 6389-6393
69. Okumura N., Terasawa F., Yonekawa O., Hamada E. and Kaneko H. (2001) Hypofibrinogenemia associated with a heterozygous C>T nucleotide substitution at position - 1138 bp of the 5′-flanking region of the fibrinogen Act-chain gene. Ann. N. Y. Acad. Sci. 936: 526-530
70. Andersen B. B., Lind B., Philips M., Hansen A. B., Ingerslev J. and Thorsen S. (1996) Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA. Thromb. Haemost. 76: 143-150
71. Vlietman J. J., Verhage J., Vos H. L., van Wijk R., Remijn J. A., van Solinge W. W. et al. (2002) Congenital afibrinogenaemia in a newborn infant due to a novel mutation in the fibrinogen Aalpha gene. Br. J. Haematol. 119: 282-283
72. Furlan M., Steinmann C., Jungo M., Bogli C., Baudo F., Redaelli R. et al. (1994) A frameshift mutation in Exon V of the Aα-chain gene leading to truncated Aα-chains in the homozygous dysfibrinogen Milano III. J. Biol. Chem. 269: 33129-33134
73. Spena S., Asselta R., Duga S., Malcovati M., Peyvandi F., Mannucci P. M. et al. (2003) Congenital afibrinogenemia: intracellular retention of fibrinogen due to a novel W437G mutation in the fibrinogen Bβ-chain gene. Biochim. Biophys. Acta 1639: 87-94
74. Asselta R., Duga S., Simonie T., Malcovati M., Santagostino E., Giangrande P. L. et al. (2000) Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation. Blood 96: 2496-2500
75. Margaglione M., Santacroce R., Colaizzo D., Seripa D., Vecchione G., Lupone M. R. et al. (2000) A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing. Blood 96: 2501-2505
76. Meyer M., Franke K., Richter W., Steiniger F., Seyfert U. T., Schenk J. et al. (2003) New molecular defects in the gamma subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover VI, Homburg VII, Stuttgart and Suhl. Thromb. Haemost. 89: 637-646